Cardiovascular Risk Reduction Recruiting Phase 2 Trials for Estradiol (DB00783)

IndicationStatusPhase
DBCOND0064693 (Cardiovascular Risk Reduction)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03815929Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young WomenPrevention